|Phoenix to Host the World's Largest Cystic Fibrosis Medical Conference Oct. 8 ...|
NACFC is sponsored by the Cystic Fibrosis Foundation, which has fueled dramatic progress in the length of life for people with the disease. Because of Foundation-supported research and care, the life expectancy of a person born with CF has doubled in ...
Business Wire (press release) - Tue, 06 Oct 2015 07:00
|Eurovision Song Contest Singer Bianca Nicholas Also Competing Against Cystic ...|
According to the Cystic Fibrosis Trust, living with cystic fibrosis (CF) is a lifetime challenge that involves a strict, daily regimen of drugs, time-consuming physiotherapy and the risk of infection that can critically escalate at any time. In spite ...
Cystic Fibrosis News Today - Tue, 06 Oct 2015 09:45
|Nivalis Therapeutics Announces Positive Phase 1b Results For N91115 In ...|
Boulder, CO (GLOBE NEWSWIRE) -- Nivalis Therapeutics, Inc. (NASDAQ:NVLS), a clinical stage pharmaceutical company focused on treating people with cystic fibrosis (CF), today announced positive topline results from a Phase 1b clinical study evaluating ...
Clinical Leader - Fri, 09 Oct 2015 02:11
|Nivalis Announces Positive Data of Phase 1b Study of Experimental Therapy ...|
Lung Disease News - Thu, 08 Oct 2015 09:41
|Nivalis Therapeutics (NVLS) Announces Positive Top-Line Data from N91115 Phase ...|
StreetInsider.com - Wed, 07 Oct 2015 13:03
|Emerging themes in idiopathic pulmonary fibrosis|
Idiopathic pulmonary fibrosis (IPF) is a chronic disease affecting the lungs and causing progressive loss of pulmonary function, ultimately leading to respiratory failure and death. There is no known cause for IPF and some genetic factors play a role ...
BMC Blogs Network (blog) - Thu, 24 Sep 2015 08:33
|Pulmonary Fibrosis Treatment Trickier Than Drug Trials Imply|
AMSTERDAM — The annual mortality rate is higher in real-world idiopathic pulmonary fibrosis (IPF) patients than in clinical trial participants, and disease is more severe, according to an analysis of an ongoing German registry. Until now, clinical ...
Medscape - Fri, 02 Oct 2015 13:54
|Cystic Fibrosis – Pipeline Review, H1 2015 by ReportBazzar|
It also reviews key players involved in the therapeutic development for Cystic Fibrosis and special features on late-stage and discontinued projects. Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3 ...
Medgadget.com (blog) - Tue, 06 Oct 2015 10:37
|EKU senior participates in highly selective cystic fibrosis research program ...|
She recalls the sheer joy she felt upon receiving news from her sister that Kalydeco, a promising new drug for cystic fibrosis patients, had been approved for children ages two to five. Bates was on her way to class when she got the call. Her squeal of ...
Richmond Register - Wed, 30 Sep 2015 14:34
|Anthera Pharmaceuticals Announces Start of Cystic Fibrosis Patient Recruitment ...|
Anthera Pharmaceuticals, Inc. announced that it is actively recruiting participants for its new Phase 3 clinical study on Cystic Fibrosis, called SOLUTION (Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin). The study is designed to ...
Lung Disease News - Mon, 05 Oct 2015 13:27